Zydus starts supplies of its COVID-19 vaccine ZyCoV-D

Indian drugmaker Zydus Cadila, part of Cadila Healthcare (BOM: 532321), today announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D, to the Indian government against its order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence Center (VTEC) at the Zydus Biotech Park in Changodar, Ahmedabad.

The group is also planning to make the vaccine available in the private market. ZyCoV-D is a three-dose vaccine administered intradermally using the painless PharmaJet needle free system, Tropis, on day 0, day 28 and day 56.

The vaccine will be priced at 265 rupees ($3.53) per dose and the applicator being offered at 93 rupees per dose excluding GST.